Skip to Main Content

Paper Details

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.
Leukemia
35
2015
Author NameAffiliation
Anna M EiringHuntsman Cancer Institute, The University of Utah
Jamshid S KhorashadHuntsman Cancer Institute, The University of Utah
Hannah M RedwineHuntsman Cancer Institute, The University of Utah
Phillip M ClairHuntsman Cancer Institute, The University of Utah
Anthony D PomicterHuntsman Cancer Institute, The University of Utah
Amber D BowlerHuntsman Cancer Institute, The University of Utah
Kara JohnsonOregon Health & Science University Knight Cancer Institute
Thomas O'HareHuntsman Cancer Institute, The University of Utah
Thomas O'HareHuntsman Cancer Institute, The University of Utah
Michael W DeiningerHuntsman Cancer Institute, The University of Utah
Michael W DeiningerHuntsman Cancer Institute, The University of Utah
  • 1 - 11

Datasets